SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Strong quarterly results and higher adjusted EBITDA guidance, alongside a DaVita DefenCath agreement that completes coverage of the five largest U.S. dialysis providers, are driving attention. Bulls see commercial momentum and short-covering potential, while skeptics point to the post-TDAPA reimbursement transition and uncertainty over future revenue, with the stocks gains seen as fragile.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares sold off after reports that Toshiba plans to double hard-drive capacity for AI data centers, raising concerns about future competition and pressure on HDD pricing. Traders split between viewing the expansion as a meaningful supply risk and calling the selloff an overreaction, with many pointing to strong AI storage demand and buying the dip.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias settlement with Teva over generic Lupkynis is the main catalyst: Teva agreed to respect the patents and delay generic entry, which traders see as strengthening Aurinias position in its remaining patent disputes. The community is broadly optimistic about further settlements and a possible acquisition, though both remain uncertain and some investors are frustrated by the stocks muted, uneven reaction.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernovas quarterly results are driving attention: revenue beat expectations and the company raised its outlook, but an earnings miss triggered a sharp selloff. Bulls call the reaction excessive given strong orders and a record backlog tied to power and data-center demand, while bears focus on valuation and weak price action.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Eras 20-year power purchase agreement with Vistra for up to 207 MW for Phase I of its Texas data-center project is drawing attention as a key step toward AI infrastructure development. Traders are bullish on the prospect of a hyperscaler tenant and further gains, while others emphasize that no tenant lease is confirmed and raise concerns about financing and potential dilution.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

Financials are under pressure as surging Treasury yields raise concerns about loan demand and capital-markets activity, outweighing the potential benefit of higher rates to bank margins. Traders point to technical breakdowns and further downside risk, while others see oversold conditions as a possible setup for a rebound.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas Phase 3 melanoma vaccine resultsmeeting recurrence-free and distant-metastasis-free survival endpoints when combined with Keytrudaare driving the discussion and optimism about Mercks oncology pipeline. Traders are debating whether the rally is justified given that full data and overall-survival results remain pending, alongside concerns about Keytrudas approaching patent cliff.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is drawing attention mainly for repeated technical-analysis posts describing consolidation and trading around support, resistance, and liquidity levels. Traders are divided between expecting a rebound or breakout and anticipating further downside; no clear company-specific catalyst dominates.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figmas results and raised full-year outlook, alongside signs that paid AI features are gaining traction, are driving debate over whether AI can boost growth or threaten the design-software business. Traders are also focused on heavy volatility, insider share sales and declining short interest, with bulls seeing potential for a rebound and bears citing dilution and profitability concerns.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

AMRN is drawing attention after a continued slide toward multi-year lows, with shareholders criticizing management and the lack of a clear path to unlock value despite the companys cash position and international growth claims. Debate centers on uncertainty around the LR-EtEPA patent and a possible strategic sale: some holders see them as potential catalysts, while skeptics point to generic competition and the companys reliance on one product.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
